News
The platform has shared three studies presented at the 2020 North American Cystic Fibrosis (CF) conference.
During the pandemic, the company experienced rapid growth as both working parents and employers sought out benefits to help families thrive in and out of the workplace.
Flare Capital's Ian Chiang and Poorwa Godbole highlight the healthcare changes COVID-19 has already spurred and discuss why they're likely to stick around for the long haul.
The company attributed much of its success to growing smartwatch sales.
The company's lead offering for employer customers has so far reached more than 250,000 users.
The study, backed by the digital therapeutics company, measured the change in clinical encounter frequency among opioid use disorder patients who were also prescribed buprenorphine.
The drug delivery and packaging company will now have control over Cohero's FDA cleared spirometer, as well as its digital platforms and sensors.
With the creation of digital twins in studies, Unlearn generates an intelligent control arm that can reduce the sample size and decrease the number of participants given the placebo.
The acquisition aims to expand Medica's geographic reach, customer base and service offerings.
Researchers out of the Cleveland Clinic discuss the digital landscape in the cardiology space.